Cooley (UK) LLP has key aptitude advising on tax aspects of capital markets transactions, including those involving multijurisdictional elements. The group is active for prominent clients such as Uber, Nvidia, and Santander. David Wilson leads the team, and is adept in the life sciences and technology sectors. Jack Jones is another name with aptitude in innovative sectors, including AI and crypto. Natasha Kaye left the team in March 2025.
Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘The team have been fantastic during the course of our work.’

  • 'The tax team is easy to work with, and they provide holistic tax advice that is clear and commercially focused. The team is responsive with deep technical knowledge.'

  • 'David Wilson is a pleasure to work with. David is hands-on and collaborative, with deep knowledge across multiple issues. With a strong network, David always knows who and when to bring in others to support his clients on niche issues where specialist expertise is needed.'

  • 'Their collaborative style and approach. They are very quick to find and connect you with the right person in the right team to address your specific issues. They are also incredibly responsive.'

  • 'In my experience, the team at Cooley are hugely pragmatic and work collaboratively with other advisors for the benefit of their clients.'

Key clients

  • Yardi Systems (majority owner of WeWork)
  • Uber
  • Nvidia
  • PetLab Co.
  • Board Intelligence
  • Battery Ventures
  • Bicycle Therapeutics plc
  • Endava Plc
  • Immunocore Holdings plc
  • Autolus Therapeutics plc
  • Click Up
  • UiPath

Work highlights

Acted for Yardi Systems as it became the majority owner of WeWork Inc, the leading provider of co-working office space, which had previously been valued at $47 billion, as that company emerged from one of the most complicated and high-profile bankruptcies of recent years.
Advised Immunocore, a global commercial-stage biotech company based in Oxfordshire, on its issuance of $402.5 million convertible notes, listed on Nasdaq.
Advised Autolus on its groundbreaking strategic collaboration with BioNTech, to advance both companies’ cancer programs toward commercialisation, as well as on a simultaneous $350 million underwritten equity offering.

Practice head

David Wilson

Other key lawyers

Jack Jones; Eerik Kukebal